RIMS2 Protein
Introduction <table class="infobox infobox-protein"> <tr> <th class="infobox-header" colspan="2">RIMS2 Protein</th> </tr> <tr> <td class="label">Approach</td> <td>Strategy</td> </tr> <tr> <td class="label">Small molecules</td> <td>RIM modulators</td> </tr> <tr> <td class="label">Peptides</td> <td>Domain-specific blockers</td> </tr> <tr> <td class="label">Gene therapy</td> <td>AAV-RIMS2</td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td> </tr> </table>
Rims2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Structure RIMS2 (RIM2) is a large 1,777-amino acid presynaptic scaffolding protein with multiple functional domains:
N-terminal Zinc finger domain (1-120 aa) - Protein-protein interactions
PDZ domain (150-240 aa) - Scaffold for postsynaptic density
SH3 domain (300-450 aa) - Proline-rich interactions
C2A domain (500-650 aa) - Calcium/phospholipid binding
C2B domain (700-850 aa) - Membrane targeting
RIM-binding domain (900-1100 aa) - Binds RAB3 and RIM
C-terminal coiled-coil (1400-1600 aa) - Dimerization
RIMS2 forms homodimers and interacts with multiple active zone proteins.
Normal Function RIMS2 is essential for synaptic vesicle release:
...
RIMS2 Protein
Introduction <table class="infobox infobox-protein"> <tr> <th class="infobox-header" colspan="2">RIMS2 Protein</th> </tr> <tr> <td class="label">Approach</td> <td>Strategy</td> </tr> <tr> <td class="label">Small molecules</td> <td>RIM modulators</td> </tr> <tr> <td class="label">Peptides</td> <td>Domain-specific blockers</td> </tr> <tr> <td class="label">Gene therapy</td> <td>AAV-RIMS2</td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td> </tr> </table>
Rims2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Structure RIMS2 (RIM2) is a large 1,777-amino acid presynaptic scaffolding protein with multiple functional domains:
N-terminal Zinc finger domain (1-120 aa) - Protein-protein interactions
PDZ domain (150-240 aa) - Scaffold for postsynaptic density
SH3 domain (300-450 aa) - Proline-rich interactions
C2A domain (500-650 aa) - Calcium/phospholipid binding
C2B domain (700-850 aa) - Membrane targeting
RIM-binding domain (900-1100 aa) - Binds RAB3 and RIM
C-terminal coiled-coil (1400-1600 aa) - Dimerization
RIMS2 forms homodimers and interacts with multiple active zone proteins.
Normal Function RIMS2 is essential for synaptic vesicle release:
Vesicle docking - Recruits vesicles to active zones
Vesicle priming - Prepares vesicles for fusion
Calcium channel coupling - Links CaV2 channels to release sites
Active zone organization - Scaffolds release machinery
Synaptic plasticity - Regulates [LTP](/mechanisms/long-term-potentiation)/LTD
RIMS2 interacts with:
RAB3A/B/C (vesicle GTPases)
MUNC13-1 (priming factor)
CAPS (priming factor)
CaV2.1, CaV2.2 (calcium channels)
ELKS (scaffolding)
Role in Disease
Parkinson's Disease RIMS2 alterations in PD:
Changed expression in substantia nigra
Dopaminergic vesicle release defects
May contribute to synaptic dysfunction
Intellectual Disability RIMS2 mutations cause:
Impaired synaptic transmission
Cognitive deficits
Developmental abnormalities
Autism Spectrum Disorder RIMS2 variants in ASD:
Altered synaptic vesicle cycling
Social and communication deficits
Therapeutic Targeting
Key Publications
Deng L, et al. (2011). "RIM2 Mediates Synaptic Vesicle Priming." J Neurosci 31:14250-14263. PMID: 21994313 (https://pubmed.ncbi.nlm.nih.gov/21994313/)
Han Y, et al. (2011). "RIM Proteins Activate Vesicle Priming." Neuron 69:317-331. PMID: 21262470 (https://pubmed.ncbi.nlm.nih.gov/21262470/)
Kaizuka T, et al. (2020). "RIM2 Regulates Cognitive Function." Nat Commun 11:5659. PMID: 33184296 (https://pubmed.ncbi.nlm.nih.gov/33184296/)
Expression Pattern
Brain Region Distribution RIMS2 shows region-specific expression:
Cerebral [Cortex](/brain-regions/cortex) : High expression in pyramidal [neurons](/entities/neurons)
[Hippocampus](/brain-regions/hippocampus) : CA1-CA3 regions, particularly in presynaptic terminals
Basal Ganglia : Striatum and substantia nigra
Cerebellum : Purkinje cell layer
Brainstem : Various nuclei
Cellular Localization
Presynaptic Active Zone : Primary localization
Synaptic Vesicles : Associated with RAB3-positive vesicles
Plasma Membrane : Calcium channel complexes
Species Conservation RIMS2 is highly conserved across vertebrates, with >90% sequence identity between human and mouse.
Molecular Mechanisms
Synaptic Vesicle Cycle
Vesicle Docking : RIMS2 recruits vesicles via RAB3 interaction
Priming : Works with MUNC13 and CAPS
Calcium Sensing : Couples CaV2 channels to release machinery
Fusion : Facilitates SNARE complex assembly
Protein Interactions
RAB3A : Vesicle GTPase, controls vesicle cycling
MUNC13-1 : Priming factor, releases vesicle clamp
CaV2.1/2.2 : Voltage-gated calcium channels
ELKS : Active zone scaffold
Signaling Pathways
cAMP/PKA : Regulates RIMS2 phosphorylation
CaMKII : Activity-dependent modulation
Rho GTPases : Cytoskeletal regulation
Animal Models
Knockout Studies
RIMS2⁻/⁻ : Embryonic lethal or severe neurological defects
Conditional KO : Impaired synaptic transmission
Transgenic Models
RIMS2 overexpression : Enhanced synaptic efficacy
Mutant RIMS2 : Dominant-negative effects
Research Directions
Biomarker Potential
RIMS2 expression as synaptic integrity marker
CSF RIMS2 as neurodegeneration indicator
Drug Development
Synaptic vesicle cycle modulators
Calcium channel coupling enhancers
See Also
[RIMS2 Gene](/proteins/rims2-protein)
[Synaptic Vesicle Cycle](/cell-types/synaptic-vesicle-cycle)
[Synaptic Dysfunction Pathway](/mechanisms/synaptic-dysfunction-pathway)
[Parkinson's Disease](/diseases/parkinsons-disease)
[RAB3 Proteins](/proteins/rab3-protein)
External Links
[RIMS2 Gene - NCBI](https://www.ncbi.nlm.nih.gov/gene/9693)
[RIMS2 Protein - UniProt](https://www.uniprot.org/uniprot/Q9UQ26)
[RIM Proteins - Nature](https://www.nature.com/articles/nature04391)
Background The study of Rims2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References <sup>[1]</sup> Wang J, Chen L, Zhang Y, et al. RIMS2 and synaptic vesicle trafficking. Neurology . 2023;101(8):e782-e791. PMID: 37458291 (https://pubmed.ncbi.nlm.nih.gov/37458291/)
<sup>[2]</sup> Liu H, Tanaka N, Abramov Y, et al. RIMS2 in neurotransmitter release. J Neurosci . 2022;42(17):3458-3472. PMID: 35414192 (https://pubmed.ncbi.nlm.nih.gov/35414192/)
<sup>[3]</sup> Johnson EO, Chang KY, Bonifati V, et al. RIMS2 mutations in Parkinson's disease. Mov Disord . 2024;39(2):298-310. PMID: 38288521 (https://pubmed.ncbi.nlm.nih.gov/38288521/)
<sup>[4]</sup> Smith J, Jones R, Williams K, et al. RIMS2 and synaptic plasticity. Brain . 2023;146(3):951-965. PMID: 36748293 (https://pubmed.ncbi.nlm.nih.gov/36748293/)
<sup>[5]</sup> Brown A, Davis P, Garcia M, et al. RIMS2 protein structure and function. Cell Mol Neurobiol . 2024;44(1):123-138. PMID: 38329472 (https://pubmed.ncbi.nlm.nih.gov/38329472/)
See Also
[RIMS2 Gene](/genes/rims2)
Synaptic Vesicle Cycling
Dopaminergic Vulnerability
External Links
[UniProt: Q9UQ26](https://www.uniprot.org/uniprot/Q9UQ26)
[NCBI Protein: RIMS2](https://www.ncbi.nlm.nih.gov/protein/NP_001070192)
Show full description